The U.S. has purchased 200 million additional Covid-19 vaccine doses from Pfizer Inc. and partner BioNTech SE , at a higher price than previous deals.
The U.S. is paying about $24 a dose, according to Pfizer, up from the $19.50 that the government paid…







